Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage
of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their
governing guidelines.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Amlodipine Amlodipine, atorvastatin drug combination Atorvastatin Atorvastatin Calcium